knowledge -WSS

knowledge

author：comprehensive 2025-09-29 10:31:35 - browse：7871

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Will an HIV vaccine ever be a reality?

WSS

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Doctors are clamoring for more clarity on Paxlovid prescribing

'Brian's Song' at 50 still offers lessons about cancer for today

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Many breast cancer patients receive more radiation than needed

Doctors push to include dialysis machines in emergency stockpile

focus

knowledge

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

NFL doctors' conflicts of interest could endanger players, report says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The stability of $0 premiums in Medicare Advantage

How one medical school became remarkably diverse

Google's generative AI to analyze medical images — and talk to docs

Heart attack and stroke risk calculators need revising

Restaurant meals are packed with calories, and we still keep eating them

The high cost of giving birth even with insurance

Restaurant meals are packed with calories, and we still keep eating them

entertainment

The Karikó problem: Lessons for funding basic research

IVG is promising — but it won’t replace IVF quite yet

Congress extends some pandemic preparedness programs

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

knowledge

hotspot

explore

explore